OTC Watch

All stocks / RMTG

Regenerative Medical Technology Group Inc. RMTG

Regenerative Medical Technology Group (RMTG): a late 10-Q notice in November 2026 and the latest annual figures in plain language. Each fact links to its SEC filing.

Late filingEstimated float OTCIDFlorida, USA
Live quote on OTC Markets

Market listing

Full name
REGENERATIVE MEDICAL TECHNOLOGY GRO
Market tier
OTC Pink Current
Trading status
Active
Last trade
Nov 16
Source: Stockwatch, 2026-11-17

News headlines

RMTG Expands Cellular Hope Institute's Cancun Clinical Facilities and Longevity Platform
2026-11-17 09:01 · News Release
RMTG's ISSCA Division Announces Successful Santa Cruz, Bolivia Conference, October 23-24
2026-10-26 07:01 · News Release
RMTG's ISSCA Division Returns to Sao Paulo for a Second Brazil Congress, November 20-21
2026-10-22 07:01 · News Release
RMTG to Go Ringside at BKFC This Weekend to Capture Content for Its "RMTG Brief" Investor-Awareness Campaign
2026-10-20 07:01 · News Release
RMTG's ISSCA Division Expands Global Online Academy With Ten New Curriculum Tracks
2026-10-08 07:02 · News Release
RMTG Broadens Longevity Footprint With New ISSCA Certification Across Adjunctive Therapies
2026-10-05 07:01 · News Release
RMTG Expands Peptide Education Platform With ISSCA Peptide Certification 2.0 and New Physician Reference Guides
2026-10-01 07:01 · News Release
RMTG's ISSCA Division to Host ISSCA 125 Global Summit in Cancun, Mexico
2026-09-21 07:01 · News Release
RMTG's ISSCA Division Launches Integrative Fellowship in Point-of-Care Regenerative Medicine through ISSCA AI(TM) Strategy
2026-09-17 07:02 · News Release
Regenerative Medical Technology Group, Inc. Details Expanded ISSCA AI(TM) Clinical Intelligence Platform, Including Protocol-Native Engine, Structured Data Assets, and Multi-Line Commercial Model
2026-09-14 07:01 · News Release
Headlines only, with links to the full item. Company press releases are written by the company.

The financial report, and what it means

Annual figures to 2025-12-31
The report says
Revenue
$5,100,315
Net loss
($7,812,409)
What it means

It spends more than it earns

Under strain

Customers paid it $5.1 million in the year. It lost $7.8 million. For every $1 that came in, about $2.53 went out.

The report says
Cash and cash equivalents
$956,718
Net cash used in operating activities
($706,519)
What it means

It has cash for a while

Steady

It had $956,718 in the bank and used about $58,877 a month. At that pace the money lasts about 16 months unless it borrows or sells more shares.

The report says
Total assets
$4,488,694
Total liabilities
$39,233,729
What it means

It owes more than it owns

Under strain

Everything the company owns adds up to $4.5 million. Its debts and unpaid bills add up to $39.2 million. That is about $8.74 owed for every $1 owned.

What this adds up to

2 of 3 checks show strain. It spends more than it earns. It owes more than it owns. These are facts from the company's own reports, not a recommendation.

Signals

Late filing2026-11-16

Filed NT 10-Q on 2026-11-16: notice that a periodic report is late.

Rule: Late-filing notice (Form NT 10-K or NT 10-Q) in the last 12 months. Source record

Estimated float2026-08-19

Estimated float about 13,738,968 shares as of 2026-08-19: 13,738,968 outstanding minus 0 held by 0 reporting insider(s).

Rule: Estimated: shares outstanding minus the latest holdings insiders reported on Forms 3/4/5. Holders of 5% or more (13D/13G) are not yet subtracted. Source record

Late filing2026-08-14

Filed NT 10-Q on 2026-08-14: notice that a periodic report is late.

Rule: Late-filing notice (Form NT 10-K or NT 10-Q) in the last 12 months. Source record

Late filing2026-05-15

Filed NT 10-Q on 2026-05-15: notice that a periodic report is late.

Rule: Late-filing notice (Form NT 10-K or NT 10-Q) in the last 12 months. Source record

Late filing2026-04-01

Filed NT 10-K on 2026-04-01: notice that a periodic report is late.

Rule: Late-filing notice (Form NT 10-K or NT 10-Q) in the last 12 months. Source record

Shares outstanding

Source: SEC filings
2025-09-30
12.5M
2025-11-14
13.1M
2025-12-31
13.1M
2026-03-31
13.1M
2026-05-14
13.1M
2026-06-09
13.1M
2026-06-30
13.7M
2026-08-19
13.7M

Price chart

Chart by TradingView. We do not store or publish prices. Live quote on OTC Markets

Recent filings

2026-11-16 NT 10-QNOTIFICATION OF LATE FILING
2026-08-28 DEF 14CDEFINITIVE INFORMATION STATEMENT
2026-08-25 8-KCURRENT REPORT
2026-08-19 10-QQUARTERLY REPORT
2026-08-18 PRE 14CPRELIMINARY INFORMATION STATEMENT
2026-08-14 NT 10-QNOTIFICATION OF LATE FILING
2026-06-09 10-QQUARTERLY REPORT
2026-05-15 NT 10-QNOTIFICATION OF LATE FILING
2026-05-14 10-KANNUAL REPORT
2026-04-01 NT 10-KNOTIFICATION OF LATE FILING
2025-11-19 10-QQUARTERLY REPORT

Common questions about RMTG

Does RMTG file reports with the SEC?

Yes. Regenerative Medical Technology Group files with the SEC under company number 0001760026. The most recent filing we hold is a NT 10-Q dated 2026-11-16.

Source record

How many RMTG shares are outstanding?

13,738,968 shares as of 2026-08-19, as reported to the SEC.

Source record

Has RMTG filed reports late?

Yes. In the last 12 months it filed 4 late-filing notices, most recently a NT 10-Q on 2026-11-16. A notice means a report was not ready on time; check whether the report followed.

Source record

Is Regenerative Medical Technology Group making money?

Customers paid it $5.1 million in the year. It lost $7.8 million. For every $1 that came in, about $2.53 went out. (Annual figures to 2025-12-31. Facts from the company's own report, not a recommendation.)

Source record